Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Biological Response Modifiers|February 1, 1987
A pilot clinical trial of the toxicity and immunorestorative effects of T cell reconstituting factor (SR 270258) in immunosuppressed cancer patientsJ L Murray, J M Reuben, T L Smith, et al.Cancer Treatment Reports|July 1, 1982
AMSA--a promising new agent in refractory acute leukemiaH J Lawrence, C A Ries, R D Reynolds, et al.Cancer Chemotherapy and Pharmacology|January 1, 1982
A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blastsD R Gandara, C A Ries, S A Schiff, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 3, 2011
The impact of the 21-gene recurrence score assay on decision making about adjuvant chemotherapy in early-stage estrogen-receptor-positive breast cancer in an oncology practice with a unified treatment policyD B Geffen, S Abu-Ghanem, N Sion-Vardy, et al.Breast (Edinburgh, Scotland)|October 13, 2009
Stage I breast cancer in a regional oncology practice in Israel 2002-2006: clinicopathologic features, risk estimation and planned therapy of 328 consecutive patientsD B Geffen, N Amir, N Sion-Vardy, et al.Oncology|August 31, 2013
Adjuvant aromatase inhibitor therapy in patients with stage I breast cancer at a regional oncology center in Israel: implementation of a 'switching' policy in postmenopausal patients after initial tamoxifenD B Geffen, M Tokar, S Abu-Ghanem, et al.Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|May 1, 1987
Evaluation of collagen/hydroxylapatite for augmenting deficient alveolar ridges: a preliminary reportD R Mehlisch, T D Taylor, D G Leibold, et al.Pageof 2